About Maxion
Maxion Therapeutics is a biotechnology company developing antibody-based drugs for previously untreatable ion channel- and G protein-coupled receptor (GPCR)-driven diseases, including autoimmune conditions, chronic pain, and cardiovascular disease.
Isomorphic Labs is applying frontier AI to help unlock deeper scientific insights, faster breakthroughs, and life-changing medicines with an ambition to solve all disease.
The future is coming. A future enabled and enriched by the incredible power of machine learning. A future in which diseases are curtailed or cured starting with better and faster drug discovery.
Description
Description
In the next two months, Creative Biolabs will host two webinars to outline the latest progress in research on CAR-T therapy against solid tumors in depth.
One of the most challenging areas in immunotherapy, CAR-T therapy against solid tumors, is undergoing a series of technical developments. This series of lectures will address two key strategies: cytokine-sensing reprogramming and secretory target delivery systems for therapeutic molecules.
The Marketing Director will provide visionary leadership and strategic direction for all marketing activities at tranScrip. This senior position is responsible for developing, implementing, and optimising a comprehensive marketing strategy that enhances tranScrip’s brand presence, drives business growth, and delivers measurable ROI across all campaigns and activities.
Stevenage, UK, 23 October 2025 - NRG Therapeutics Ltd. (“NRG”), an innovative neuroscience company targeting a novel mechanism to address mitochondrial dysfunction, is pleased to announce expansion of its team with the addition of three senior appointments in newly created roles: Sarah Almond as VP of Translational Biology; David Brocklebank as Director of Clinical Operations; and Kathryn Oliver as Director of Project Management.
New Leadership Development Programme for the Life Sciences
The Expert Leader Programme is purposefully designed to support the unique demands of leading small-to-medium sized Life Science organisations in the United Kingdom.
It is specifically for:
- Scientific and non-scientific experts who have transitioned into key leadership roles
- Leaders who lead experts or interdisciplinary teams
- Those who are committed to developing their leadership expertise
Data – How to maximise your greatest business asset. Getting you out of a world of decision-making pain.
Does this sound familiar to you:
This session will be led by Mike Basketter, Commercial Director at CRM Insights.
LONDON, UK - October 22, 2025 – Coulter Partners, the global expert building leadership teams for Health, Science and Technology innovation businesses, successfully completed a search assignment for Tristel plc (AIM: TSTL) and is pleased to announce the placement of Anna Wasyl as Chief Financial Officer (CFO).